These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20082248)

  • 1. Clinical study on treatment of hyperuricaemia by retention enema of Chinese herbal medicine combined with allopurinol.
    Chen Q; Ma L; Akebaier W
    Chin J Integr Med; 2009 Dec; 15(6):431-4. PubMed ID: 20082248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of Chinese herbal enema therapy combined basic treatment on BUN, SCr, UA, and IS in chronic renal failure patients].
    Zou C; Wu YC; Lin QZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Sep; 32(9):1192-5. PubMed ID: 23185756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia, a traditional Chinese herbal medicine.
    Wu XH; Wang CZ; Wang SQ; Mi C; He Y; Zhang J; Zhang YW; Anderson S; Yuan CS
    J Ethnopharmacol; 2015 Mar; 162():362-8. PubMed ID: 25617746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of inflammatory bowel disease with Chinese drugs administered by both oral intake and retention enema.
    Ling XH; Yu X; Kong DJ; Hu CY; Hong Y; Yang XM
    Chin J Integr Med; 2010 Jun; 16(3):222-8. PubMed ID: 20694776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of treatment on chronic uric acid nephropathy by integrating Western and traditional Chinese medicine].
    Wu X; Li J; Mo S; Liu H; Zhou Y; Shen W
    Zhong Yao Cai; 2002 Jan; 25(1):72-5. PubMed ID: 12583246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Rhizoma Polygoni Cuspidati and Ramulus Cinnamomi compatibility on uric acid metabolism and urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in rats with hyperuricemia.
    Han B; Zhu CX; Shi W; Huang HZ; Hu XG; Zhou XM; Lei M; Li Z
    Chin J Integr Med; 2017 Jul; 23(7):535-542. PubMed ID: 28116659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5.
    Liu X; Wang H; Ma R; Shao L; Zhang W; Jiang W; Luo C; Zhai T; Xu Y
    Clin Exp Nephrol; 2019 Mar; 23(3):362-370. PubMed ID: 30291473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.
    Xu S; Liu X; Ming J; Chen S; Wang Y; Liu X; Liu H; Peng Y; Wang J; Lin J; Ji H; Liu B; Lu Y; Liu P; Zhang Y; Ji Q
    Int J Rheum Dis; 2015 Jul; 18(6):669-78. PubMed ID: 26013187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.
    Feher MD; Hepburn AL; Hogarth MB; Ball SG; Kaye SA
    Rheumatology (Oxford); 2003 Feb; 42(2):321-5. PubMed ID: 12595630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia.
    Tsuji T; Ohishi K; Takeda A; Goto D; Sato T; Ohashi N; Fujigaki Y; Kato A; Yasuda H
    Clin Exp Nephrol; 2018 Dec; 22(6):1300-1308. PubMed ID: 29700702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients.
    Li Y; Liu M; Zhang X; Lu Y; Meng J
    Ren Fail; 2019 Nov; 41(1):595-599. PubMed ID: 31267805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Yellow-dragon Wonderful-seed Formula" for hyperuricemia in gout patients with dampness-heat pouring downward pattern: a pilot randomized controlled trial.
    Yu XN; Wu HY; Deng YP; Zhuang GT; Tan BH; Huang YZ; Tang SY; Tu X; Jordan JB; Zhong S
    Trials; 2018 Oct; 19(1):551. PubMed ID: 30314508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis.
    Feng X; Dong K; Pham D; Pence S; Inciardi J; Bhutada NS
    J Clin Pharm Ther; 2013 Aug; 38(4):301-8. PubMed ID: 23550846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of jianpihuashi decoction on rats with hyperuricemia].
    Chen JW; Zhou Y; Xue ZY; Li C; Guo J; Zhou LY; Jiang JM
    Zhong Yao Cai; 2013 Sep; 36(9):1486-9. PubMed ID: 24620698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy and safety between febuxostat and allopurinol in early post-renal transplant recipients with new onset of hyperuricemia.
    Shen X; Li J; Fu Q; Liu L; Gao X; Chen X; Chen P; Wang C
    J Clin Pharm Ther; 2019 Apr; 44(2):318-326. PubMed ID: 30582178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total saponins from dioscorea septemloba thunb reduce serum uric acid levels in rats with hyperuricemia through OATP1A1 up-regulation.
    Chen Y; Chen XL; Xiang T; Sun BG; Luo HX; Liu MT; Chen ZX; Zhang SJ; Wang CJ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):237-242. PubMed ID: 27072969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia treatment in acute heart failure patients does not improve their long-term prognosis: A propensity score matched analysis from the AHEAD registry.
    Pavlusova M; Jarkovsky J; Benesova K; Vitovec J; Linhart A; Widimsky P; Spinarova L; Zeman K; Belohlavek J; Malek F; Felsoci M; Kettner J; Ostadal P; Cihalik C; Spac J; Al-Hiti H; Fedorco M; Fojt R; Kruger A; Malek J; Mikusova T; Monhart Z; Bohacova S; Pohludkova L; Rohac F; Vaclavik J; Vondrakova D; Vyskocilova K; Bambuch M; Dostalova G; Havranek S; Svobodová I; Dusek L; Spinar J; Miklik R; Parenica J
    Clin Cardiol; 2019 Aug; 42(8):720-727. PubMed ID: 31119751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S44-9. PubMed ID: 21654269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.